









Markets
/
Stocks
/
nasdaq-insp
/

Inspire Medical Systems Inc

INSP

50.130USD

-0.320-0.63%

Close 03/27, 16:00（ET）Quotes delayed by 15 min

1.01BMarket Cap

10.12P/E TTM



Inspire Medical Systems Inc

50.130

-0.320-0.63%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Inspire Medical Systems Inc

Currency: USD Updated: 2026-03-27

Key Insights

Inspire Medical Systems Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 74 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 89.99.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Inspire Medical Systems Inc's Score

Industry at a Glance

Industry Ranking

74 / 208

Overall Ranking

191 / 4542

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Inspire Medical Systems Inc Highlights

StrengthsRisks

Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 45.96% year-on-year.

Fairly Valued

The company’s latest PE is 10.12, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 33.78M shares, decreasing 16.49% quarter-over-quarter.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 210.00 shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 1.56.

Analyst Rating

Based on 19 analysts

Hold

Current Rating

89.987

Target Price

+72.82%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-27

The current financial score of Inspire Medical Systems Inc is 8.35, ranking 38 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 269.08M, representing a year-over-year increase of 12.25%, while its net profit experienced a year-over-year increase of 286.36%.

Score

Industry at a Glance

Previous score

8.35

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.05

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

8.38

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

8.80

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.54

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Inspire Medical Systems Inc's Company Valuation

Currency: USD Updated: 2026-03-27

The current valuation score of Inspire Medical Systems Inc is 4.60, ranking 190 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 10.12, which is 10103.72% below the recent high of 1033.03 and 4785.76% above the recent low of -474.39.

Score

Industry at a Glance

Previous score

4.60

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 74/208

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-27

The current earnings forecast score of Inspire Medical Systems Inc is 7.05, ranking 152 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 127.50, with a high of 180.00 and a low of 81.00.

Score

Industry at a Glance

Previous score

7.05

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 19 analysts

Hold

Current Rating

89.987

Target Price

+72.82%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

115

Total

Median

Average

Company name

Ratings

Analysts

Inspire Medical Systems Inc

INSP

Medtronic PLC

MDT

Stryker Corp

SYK

Dexcom Inc

DXCM

Zimmer Biomet Holdings Inc

ZBH

Abbott Laboratories

ABT

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-27

The current price momentum score of Inspire Medical Systems Inc is 5.89, ranking 169 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 61.49 and the support level at 43.77, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

5.75

Change

0.14

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.378

Sell

RSI(14)

26.229

Sell

STOCH(KDJ)(9,3,3)

8.705

Oversold

ATR(14)

2.965

Low Volatility

CCI(14)

-125.961

Sell

Williams %R

89.989

Oversold

TRIX(12,20)

-0.940

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

51.244

Sell

MA10

53.504

Sell

MA20

57.680

Sell

MA50

66.184

Sell

MA100

85.124

Sell

MA200

92.320

Sell

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of Inspire Medical Systems Inc is 10.00, ranking 1 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 116.26%, representing a quarter-over-quarter increase of 4.62%. The largest institutional shareholder is The Vanguard, holding a total of 2.95M shares, representing 10.31% of shares outstanding, with 5.57% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

3.19M

-8.69%

The Vanguard Group, Inc.

Star Investors

2.99M

-6.37%

Deerfield Management Company, L.P.

1.48M

+40.91%

William Blair Investment Management, LLC

1.30M

+68.70%

State Street Investment Management (US)

979.31K

-5.00%

Artisan Partners Limited Partnership

526.24K

+45.24%

Fuller & Thaler Asset Management Inc.

423.00K

Risk Assessment

Currency: USD Updated: 2026-03-27

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Inspire Medical Systems Inc is 4.13, ranking 110 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.83. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.